Biology Reference
In-Depth Information
Inkinen K, Soots A, Krogerus L, Loginov R, Bruggeman C, Lautenschlager I (2005)
Cytomegalovirus enhances expression of growth factors during the development of chronic
allograft nephropathy in rats. Transpl Int 18:743-749
Keese CR, Wegener J, Walker SR, Giaever I (2004) Electrical wound-healing assay for cells in
vitro. Proc Natl Acad Sci U S A 101:1554-1559
Kent D, Sheridan C (2003) Choroidal neovascularization: a wound healing perspective. Mol Vis
9:747-755
Khurana R, Simons
(2003) Insights from angiogenesis trials using fibroblast growth factor for
advanced arteriosclerotic disease. Trends Cardiovasc Med 13:116-122
Klempnauer J, Marquarding E (1989) RT1.C and rat bone marrow transplantation. Transplant
Proc 21:3292
Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ (1993) Cytomegalovirus
infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allo-
grafts. J Clin Invest 92:549-558
Lemstrom K, Koskinen P, Krogerus L, Daemen Μ, Bruggeman CA, Hayry PJ (1995)
Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in
rat cardiac allografts after cytomegalovirus infection. Circulation 92:2594-2604
Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS (1989) Functions of vascular wall cells
related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc
21:3677-3684
Lubaroff DM, Rasmussen GT, Hunt HD (1989) The RT6 T cell antigen: its role in the identification
of functional subsets and in T cell activation. Transplant Proc 21:3251
Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME (1983)
Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2:644-647
Melnick JL, Adam E, DeBakey ME (1998) The link between CMV and atherosclerosis. Infect
Med 15:479-486
Merigan TC, Renlund DG, Keay S et al (1992) A controlled trial of ganciclovir to prevent cytome-
galovirus disease after heart transplantation. N Engl J Med 326:1182-1186
Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES (2006)
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to
facilitate dissemination. Blood 107:30-38
Orloff SL (1999) Elimination of donor-specific alloreactivity by bone marrow chimerism prevents
cytomegalovirus accelerated transplant vascular sclerosis in rat small bowel transplants. J Clin
Virol 12:142
Orloff SL, Yin Q, Corless CL, Orloff MS, Rabkin JM, Wagner CR (2000) Tolerance induced by
bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel
transplant chronic rejection. Transplantation 69:1295-1303
Orloff SL, Streblow DN, Soderberg-Naucler C, Yin Q, Kreklywich C, Corless CL, Smith PA,
Loomis CB, Mills LK, Cook JW, Bruggeman CA, Nelson JA, Wagner CR (2002) Elimination
of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat
small bowel and heart transplants. Transplantation 73:679-688
Reinhardt B, Mertens T, Mayr-Beyrle U, Frank H, Luske A, Schierling K, Waltenberger J (2005a)
HCMV infection of human vascular smooth muscle cells leads to enhanced expression of
functionally intact PDGF beta-receptor. Cardiovasc Res 67:151-160
Reinhardt B, Schaarschmidt P, Bossert A, Luske A, Finkenzeller G, Mertens T, Michel D (2005b)
Upregulation of functionally active vascular endothelial growth factor by human cytomegalo-
virus. J Gen Virol 86:23-30
Reinhardt B, Winkler
Μ
, Schaarschmidt P, Pretsch R, Zhou S, Vaida B, Schmid-Kotsas A, Michel
D, Walther P, Bachem
Μ
, Mertens T (2006) Human cytomegalovirus-induced reduction of
extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in
vasculopathies? J Gen Virol 87:2849-2858
Rubin RH (1999) Importance of CMV in the transplant population. Transplant Infect Dis 1:3-7
Schaarschmidt P, Reinhardt B, Michel D, Vaida B, Mayr K, Luske A, Baur R, Gschwend J,
Kleinschmidt K, Kountidis
Μ
Μ
, Wenderoth U, Voisard R, Mertens T (1999) Altered expression
